Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Oxford BioDynamics ( (GB:OBD) ) just unveiled an announcement.
Oxford BioDynamics has reported a change in major holdings, with Arbuthnot Latham (Nominees) Limited reducing its voting rights in the company from 9.13% to 3.79%. This notification follows a successful capital raise by Oxford BioDynamics, where the company secured £7 million through a share placing, resulting in the issuance of 1.4 billion new Ordinary Shares. This development is significant for the company as it strengthens its financial position to support ongoing operations and growth initiatives.
More about Oxford BioDynamics
Oxford BioDynamics PLC operates in the biotechnology industry, specializing in the development and commercialization of a proprietary technology for epigenetic biomarkers. The company focuses on applying this technology to facilitate personalized medicine and improve patient care.
YTD Price Performance: -66.67%
Average Trading Volume: 3,491,952
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £2.1M
For a thorough assessment of OBD stock, go to TipRanks’ Stock Analysis page.
